France· FR:67716786
CHENODEOXYCHOLIC ACID LEADIANT 250 mg, gélules
A medicinal product containing acide chénodésoxycholique, registered in France by LEADIANT BIOSCIENCES IRELAND (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE CHÉNODÉSOXYCHOLIQUE
- Manufacturer
- LEADIANT BIOSCIENCES IRELAND (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400930088791plaquette(s) thermoformée(s) PVC aluminium de 100 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide chénodésoxycholique in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomChenodeoxycholic acid 250mg capsulesLeadiant Biosciences Ltd
- SwitzerlandAcido chenodesossicolico Leadiant 250 mg, capsula rigidaCD PHARMA (SUISSE) SA
- CzechiaCHENODEOXYCHOLIC ACID LEADIANTLeadiant Biosciences Ireland Limited, Dublin
- SpainÁCIDO QUENODESOXICÓLICO LEADIANT 250 MG CÁPSULAS DURASLeadiant Gmbh
- FinlandChenodeoxycholic Acid LeadiantLeadiant Biosciences Ireland Limited
- IrelandChenodeoxycholic acid Leadiant 250 mg hard capsulesLeadiant Biosciences Ireland Limited
- IcelandChenodeoxycholic acid LeadiantLeadiant GmbH
- NetherlandsChenodeoxycholic acid Leadiant 250 mg harde capsulesLeadiant Biosciences Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Iceland · Chenodeoxycholic Acid, Chenodeoxycholic Acid Leadiant
- Liechtenstein · Chenodeoxycholic Acid, Chenodeoxycholic Acid Leadiant
- Norway · Chenodeoxycholic Acid, Chenodeoxycholic Acid Leadiant
- Portugal · Xebyl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b51671fe-8689-4f87-81b5-2217efef6a88 GET /v1/drugs/b51671fe-8689-4f87-81b5-2217efef6a88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67716786",
"date_amm": "2017-04-10",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1110",
"substance": "ACIDE CHÉNODÉSOXYCHOLIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about acide chénodésoxycholique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.